J. Fomitcheva et al., CHARACTERIZATION OF KE-6, A NEW 17-BETA-HYDROXYSTEROID-DEHYDROGENASE,AND ITS EXPRESSION IN GONADAL TISSUES, The Journal of biological chemistry, 273(35), 1998, pp. 22664-22671
The abnormal regulation of the Ke 6 gene has been linked to the develo
pment of recessive polycystic kidney disease in the mouse. In this rep
ort, we have shown that Ke 6 is a 17 beta-hydroxysteroid dehydrogenase
and can regulate the concentration of biologically active estrogens a
nd androgens. The Ke 6 enzyme is preferentially an oxidative enzyme an
d inactivates estradiol, testosterone, and dihydrotestosterone. Howeve
r, the enzyme has some reductive activity and can synthesize estradiol
from estrone. We find that the Ke 6 gene is expressed within the ovar
ies and testes. The presence of Ke 6 protein within the cumulus cells
surrounding the oocyte places it in a strategic location to control th
e level of steroids to which the egg is exposed. Previously, it had be
en shown that glucocorticoids can induce renal cysts in the neonatal r
odent, only when given at a narrow time window of postnatal kidney dev
elopment. We propose that the reduction in the level of Ke 6 enzyme, w
hich occurs in the cpk, jck, and pcy mice, may lead to abnormal elevat
ions in local level of sex steroids, which either directly or indirect
ly via abnormal glucocorticoid metabolism result in recessive renal cy
stic disease, a developmental disorder of the kidney.